Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment

This publication has 93 references indexed in Scilit:

• Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
  Cancer Cell, 2012
• Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
  Nature, 2012
• Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
  Proceedings of the National Academy of Sciences, 2011
• Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
  Hepatology, 2011
• Increased Activation of the Wnt/β-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice
  The Journal of Pharmacology and Experimental Therapeutics, 2011
• High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis
  Hepatology, 2010
• Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
  New England Journal of Medicine, 2010
• Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
  Cell, 2010
• Hedgehog-Mediated Epithelial-to-Mesenchymal Transition and Fibrogenic Repair in Nonalcoholic Fatty Liver Disease
  Gastroenterology, 2009
• Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
  Gastroenterology, 2009